Our product range includes a wide range of fempro 2.5mg letrozole.
₹ 70 / Tablet Get Latest Price
| Brand | LETRO |
| Dose/Strength | 2.5 mg |
| Packaging Size | 10 s |
| Usage/Application | Hospital |
Fempro 2.5mg (Letrozole) is a medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Letrozole belongs to a class of drugs known as aromatase inhibitors, which work by lowering the levels of estrogen in the body. Estrogen can promote the growth of certain types of breast cancer, and by reducing estrogen production, Letrozole helps slow down or stop the growth of hormone-sensitive cancer cells.
Fempro 2.5mg (Letrozole) is commonly used for:
Letrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogen. In postmenopausal women, the ovaries no longer produce estrogen, so aromatase takes over the role of estrogen production. By blocking this enzyme, Fempro reduces estrogen levels in the body, which can prevent the growth of estrogen-dependent cancer cells.
Dosage and Administration: Fempro is typically taken orally, once a day at a dose of 2.5 mg. The treatment is often continued for several years, depending on the type of cancer and the treatment plan. It is usually well tolerated, but side effects should be monitored.
Common side effects include:
Serious side effects, though less common, can include:
Regular monitoring of bone health (via bone density tests) and liver function is recommended during treatment.
Fempro is often used in combination with other treatments (like chemotherapy or radiotherapy), but it’s important to follow the treatment plan prescribed by the healthcare provider. Always report any unusual symptoms or side effects to your doctor.
Rx Patel (COO)
SP Elixir (OPC) Private Limited
F.F.-32, Shakti Arcade, Opp.Auda Water Tank, Science City Road, Sola
Ahmedabad - 380060, Gujarat, India